Currently, out of the existing stock ratings of Judah Frommer - 152 which are a Buy (72.04%), 55 which are a Hold (26.07%), 4 which are a Sell (1.9%)

Judah Frommer

Work Performance Price Targets & Ratings Chart

Analyst Judah Frommer works at CREDIT SUISSE and is covering Consumer Defensive, Consumer Cyclical, Healthcare sectors with 357 price targets and ratings displayed on 29 stocks.

Judah Frommer's average stock forecast success ratio is 45.96% with an average time for price targets to be met of 112.07 days.

Most recent stock forecast was given on JSPR, at 14-Aug-2023.

Wall Street Analyst Judah Frommer

Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 5/15/2023. The price target of $151 was fulfilled within 1 day with a profit of $6.19 (3.94%) receiving and performance score of 39.38.

Average potential price target upside

of $16.03 (27.06%) on SYY.
of $14.49 (16.3%) on DLTR (DOLLAR TREE).
of $14.46 (14.26%) on SRPT (SAREPTA THERAPEUTICS).

DLTR Dollar Tree FIVE Five Below JSPR KR The Kroger Co OLLI Ollie's Bargain Outlet Holdings SYY USFD US Foods SFM Sprouts Farmers Market ATAI CRTX Cortexyme EFTR ESPR Esperion Therapeutics FLXN Flexion Therapeutics FULC INBX Inhibrx PEAR PTCT PTC Therapeutics ABOS RNA DG Dollar General IKNA PFGC Performance Food Group Company SRPT Sarepta Therapeutics STOK Stoke Therapeutics BJ BJ's Wholesale Club Holdings AKLI CADL INSM Insmed QURE uniQure N.V

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Joseph Feldman (TELSEY ADVISORY)